Agency deficiencies
Severity: majorRespond to agency requests within the prescribed timeline.
Issued May 29, 2025
Issued
May 29, 2025
Application
NDA 505b1 • 219029
Review center
CDER
Stage
Final Decision
Letter type
Complete Response Letter
This section serves as a representation of an electronically signed record, detailing the electronic signature and associated metadata such as the signing date, time, and a reference ID.
No specific deficiencies could be extracted from the provided truncated letter text. The letter indicates a complete response, suggesting the application is not ready for approval.
Respond to agency requests within the prescribed timeline.
The provided letter text is too truncated to identify specific themes or issues leading to the complete response. The decision is a complete response, indicating the application is not approvable in its current form.
Regulatory change impact: Pending sponsor mitigation plan
Approval likelihood after response: 25%
Document viewer
Read the FDA letter and send context to the co-pilot at any time.